Showing results (31-40 of 212) with videos related to
Sort By:
Pageof 22
Cancer|February 10, 2010
Which AML subsets benefit from leukemic cell priming during chemotherapy? Long-term analysis of the ALFA-9802 GM-CSF studyXavier Thomas, Emmanuel Raffoux, Aline Renneville, et al.International Journal of Molecular Sciences|August 13, 2020
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia TreatmentLaurène Fenwarth, Elise Fournier, Meyling Cheok, et al.British Journal of Haematology|February 23, 2016
Multi-loci diagnosis of acute lymphoblastic leukaemia with high-throughput sequencing and bioinformatics analysisYann Ferret, Aurélie Caillault, Shéhérazade Sebda, et al.Leukemia Research|August 9, 2012
Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosisEdouard Cornet, Florent Dumézy, Christophe Roumier, et al.Journal of Natural Products|March 25, 2010
Humulane and germacrane sesquiterpenes from Ferula lyciaRacha Alkhatib, Thierry Hennebelle, Sami Joha, et al.Leukemia Research|December 2, 2011
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemiaEmna Abdelhamid, Claude Preudhomme, Nathalie Helevaut, et al.European Journal of Haematology|March 4, 2016
Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcriptNicolas Duployez, Olivier Nibourel, Benoît Ducourneau, et al.Leukemia Research|May 20, 2014
Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidineCecile Bally, Lionel Adès, Aline Renneville, et al.Haematologica|December 5, 2015
Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trialChristophe Willekens, Odile Blanchet, Aline Renneville, et al.Current Research in Translational Medicine|February 13, 2025
Denutrition status prevails over a standard AML risk assessment in older adultsLaura Simon, Alexis Caulier, Céline Berthon, et al.Pageof 22